Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

The Removal of Endo- and Enterotoxins From Bacteriophage Preparations.

Hietala V, Horsma-Heikkinen J, Carron A, Skurnik M, Kiljunen S.

Front Microbiol. 2019 Jul 23;10:1674. doi: 10.3389/fmicb.2019.01674. eCollection 2019.

2.

Characterization of vB_ApiM_fHyAci03, a novel lytic bacteriophage that infects clinical Acinetobacter strains.

Pulkkinen E, Wicklund A, Oduor JMO, Skurnik M, Kiljunen S.

Arch Virol. 2019 Aug;164(8):2197-2199. doi: 10.1007/s00705-019-04284-z. Epub 2019 May 23.

3.

Genomic characterization of four novel Staphylococcus myoviruses.

Oduor JMO, Kiljunen S, Kadija E, Mureithi MW, Nyachieo A, Skurnik M.

Arch Virol. 2019 Aug;164(8):2171-2173. doi: 10.1007/s00705-019-04267-0. Epub 2019 May 15.

PMID:
31093759
4.

Molecular Factors of Hypochlorite Tolerance in the Hypersaline Archaeon Haloferax volcanii.

Gomez M, Leung W, Dantuluri S, Pillai A, Gani Z, Hwang S, McMillan LJ, Kiljunen S, Savilahti H, Maupin-Furlow JA.

Genes (Basel). 2018 Nov 20;9(11). pii: E562. doi: 10.3390/genes9110562.

5.

Complete Genome Sequences of Two Escherichia Phages Isolated from Wastewater in Finland.

Kiljunen S, Wicklund A, Skurnik M.

Genome Announc. 2018 May 31;6(22). pii: e00401-18. doi: 10.1128/genomeA.00401-18.

6.

Mu transpososome activity-profiling yields hyperactive MuA variants for highly efficient genetic and genome engineering.

Rasila TS, Pulkkinen E, Kiljunen S, Haapa-Paananen S, Pajunen MI, Salminen A, Paulin L, Vihinen M, Rice PA, Savilahti H.

Nucleic Acids Res. 2018 May 18;46(9):4649-4661. doi: 10.1093/nar/gkx1281.

7.

Characterization of vB_SauM-fRuSau02, a Twort-Like Bacteriophage Isolated from a Therapeutic Phage Cocktail.

Leskinen K, Tuomala H, Wicklund A, Horsma-Heikkinen J, Kuusela P, Skurnik M, Kiljunen S.

Viruses. 2017 Sep 14;9(9). pii: E258. doi: 10.3390/v9090258.

8.

Screening of a Haloferax volcanii Transposon Library Reveals Novel Motility and Adhesion Mutants.

Legerme G, Yang E, Esquivel RN, Kiljunen S, Savilahti H, Pohlschroder M.

Life (Basel). 2016 Nov 26;6(4). pii: E41.

9.

Integrins are not essential for entry of coxsackievirus A9 into SW480 human colon adenocarcinoma cells.

Heikkilä O, Merilahti P, Hakanen M, Karelehto E, Alanko J, Sukki M, Kiljunen S, Susi P.

Virol J. 2016 Oct 18;13(1):171.

10.

Transposon Insertion Mutagenesis for Archaeal Gene Discovery.

Kiljunen S, Pajunen MI, Savilahti H.

Methods Mol Biol. 2017;1498:309-320.

PMID:
27709584
11.

[Possibilities of bacteriophage therapy].

Skurnik M, Kiljunen S.

Duodecim. 2016;132(8):712-9. Finnish.

PMID:
27244930
12.

Generation of comprehensive transposon insertion mutant library for the model archaeon, Haloferax volcanii, and its use for gene discovery.

Kiljunen S, Pajunen MI, Dilks K, Storf S, Pohlschroder M, Savilahti H.

BMC Biol. 2014 Dec 9;12:103. doi: 10.1186/s12915-014-0103-3.

13.

Characterization of the genome, proteome, and structure of yersiniophage ϕR1-37.

Skurnik M, Hyytiäinen HJ, Happonen LJ, Kiljunen S, Datta N, Mattinen L, Williamson K, Kristo P, Szeliga M, Kalin-Mänttäri L, Ahola-Iivarinen E, Kalkkinen N, Butcher SJ.

J Virol. 2012 Dec;86(23):12625-42. doi: 10.1128/JVI.01783-12. Epub 2012 Sep 12.

14.

Identification of the lipopolysaccharide core of Yersinia pestis and Yersinia pseudotuberculosis as the receptor for bacteriophage φA1122.

Kiljunen S, Datta N, Dentovskaya SV, Anisimov AP, Knirel YA, Bengoechea JA, Holst O, Skurnik M.

J Bacteriol. 2011 Sep;193(18):4963-72. doi: 10.1128/JB.00339-11. Epub 2011 Jul 15.

15.

Universal platform for quantitative analysis of DNA transposition.

Pajunen MI, Rasila TS, Happonen LJ, Lamberg A, Haapa-Paananen S, Kiljunen S, Savilahti H.

Mob DNA. 2010 Nov 26;1(1):24. doi: 10.1186/1759-8753-1-24.

16.

Internalization of coxsackievirus A9 is mediated by {beta}2-microglobulin, dynamin, and Arf6 but not by caveolin-1 or clathrin.

Heikkilä O, Susi P, Tevaluoto T, Härmä H, Marjomäki V, Hyypiä T, Kiljunen S.

J Virol. 2010 Apr;84(7):3666-81. doi: 10.1128/JVI.01340-09. Epub 2010 Jan 20.

17.

Biotechnological challenges of phage therapy.

Skurnik M, Pajunen M, Kiljunen S.

Biotechnol Lett. 2007 Jul;29(7):995-1003. Epub 2007 Mar 16. Review.

PMID:
17364214
18.

Yersiniophage phiR1-37 is a tailed bacteriophage having a 270 kb DNA genome with thymidine replaced by deoxyuridine.

Kiljunen S, Hakala K, Pinta E, Huttunen S, Pluta P, Gador A, Lönnberg H, Skurnik M.

Microbiology. 2005 Dec;151(Pt 12):4093-102.

PMID:
16339954
19.

Nonessential genes of phage phiYeO3-12 include genes involved in adaptation to growth on Yersinia enterocolitica serotype O:3.

Kiljunen S, Vilen H, Pajunen M, Savilahti H, Skurnik M.

J Bacteriol. 2005 Feb;187(4):1405-14.

20.

Transposon mutagenesis of the phage phi YeO3-12.

Kiljunen S, Vilen H, Savilahti H, Skurnik M.

Adv Exp Med Biol. 2003;529:245-8. No abstract available.

PMID:
12756765
21.

Expression of heterologous O-antigen in Yersinia pestis KIM does not affect virulence by the intravenous route.

Oyston PC, Prior JL, Kiljunen S, Skurnik M, Hill J, Titball RW.

J Med Microbiol. 2003 Apr;52(Pt 4):289-94.

PMID:
12676866
22.

Complete genomic sequence of the lytic bacteriophage phiYeO3-12 of Yersinia enterocolitica serotype O:3.

Pajunen MI, Kiljunen SJ, Söderholm ME, Skurnik M.

J Bacteriol. 2001 Mar;183(6):1928-37.

23.

Supplemental Content

Loading ...
Support Center